Positive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantation

Digestive Surgery

Volumn 26, Issue 6, 2010, Pages 482-486

  Sugawara, Yasuhiko ^a   Tamura, Sumihito ^a   Kaneko, Junichi ^a   Togashi, Junichi ^a   Makuuchi, Masatoshi ^a   Kokudo, Norihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Acute rejection; Living donor liver transplantation; Preformed antibodies

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ALLOTRANSPLANTATION; ARTICLE; B LYMPHOCYTE; COMPARATIVE STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 73649125010     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000253873     Document Type: Article

References (32)

1. Kissmeyer-Nielsen F, Olsen S, Peterson VP, Fjeldhorez O: Hyperacute rejection of kidney allograft associated with pre-existing humoral antibodies against donor cells. Lancet 1966;ii:662-665.
2. Starzl TE, Lerner PA, Dixon FJ, Groth CG, Brettschneider L, Terasaki PI: Schwartzman reaction after human renal homotransplantation. N Engl J Med 1968; 278: 642-1628
3. McCloskey D, Festenstein H, Banner N, Hawes R, Holmes J, Khaghani A: The effect of HLA, lymphocytotoxic antibody status and crossmatch result on cardiac survival. Transplant Proc 1989; 21: 804-805.
4. Castillo-Rama M, Castro MJ, Bernardo I, Meneu-Diaz JC, Elola-Olaso AM, Calleja-Antolin SM, Romo E, Morales P, Moreno E, Paz-Artal E: Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility. Liver Transpl 2008; 14: 554-562.
5. Muro M, Marin L, Miras M, Moya-Quiles R, Minguela A, Sánchez-Bueno F, Bermejo J, Robles R, Ramírez P, García-Alonso A, Parrilla P, Alvarez-López MR: Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre. Transpl Immunol 2005; 14: 91-97.
6. Iwatsuki S, Rabin BS, Shaw BW Jr, Starzl TE: Liver transplantation against T cell-positive warm crossmatches. Transplant Proc 1984; 16: 1427-1429.
7. Iwatsuki S, Iwaki Y, Kano T, Klintmalm G, Koep LJ, Weil R, Starzl TE: Successful liver transplantation from crossmatch-positive donors. Transplant Proc 1981; 13: 286-287.
8. Gordon RD, Fung JJ, Markus B, Fox I, Iwatsuki S, Esquivel CO, Tzakis A, Todo S, Starzl TE: The antibody crossmatch in liver transplantation. Surgery 1986; 100: 705-715.
9. Fujita S, Rosen C, Reed A, Langham MR Jr, Howard RJ, Lauwers GY, Scornik JC: Significance of preformed anti-donor antibodies in liver transplantation. Transplantation 1997; 63: 84-88.
10. Matinlauri IH, Höckerstedt KA, Isoniemi HM: Equal overall rejection rate in pretransplant flow-cytometric cross-match negative and positive adult recipients in liver transplantation. Clin Transplant 2005; 19: 626-631.
11. Takaya S, Bronsther O, Iwaki Y, Nakamura K, Abu-Elmagd K, Yagihashi A, Demetris AJ, Kobayashi M, Todo S, Tzakis AG: The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992; 53: 400-406.
12. Donaldson PT, Alexander GJ, O'Grady J, Neuberger J, Portmann B, Thick M, Davis H, Calne RY, Williams R: Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet 1987; 8539: 945-951.
13. Bathgate AJ, McColl M, Garden OJ, Forsythe JL, Madhavan KK, Hayes PC: The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection. Liver Transpl Surg 1998; 4: 280-284.
14. Katz SM, Kimball PM, Ozaki C, Monsour H, Clark J, Cavazos D, Kahan BD, Wood RP, Kerman RH: Positive pretransplant crossmatches predict early graft loss in liver allograft recipients. Transplantation 1994; 57: 616-620.
15. Bishara A, Brautbar C, Eid A, Scherman L, Ilan Y, Safadi R: Is presensitization relevant to liver transplantation outcome? Hum Immunol 2002; 63: 742-750.
16. Hathaway M, Gunson BK, Keogh AC, Briggs D, McMaster P, Neuberger JM: A positive crossmatch in liver transplantation-no effect or inappropriate analysis? A prospective study. Transplantation 1997; 64: 54-59.
17. Demetris AJ, Murase N, Nakamura K, Iwaki Y, Yagihashi A, Valdivia L, Todo S, Iwatsuki S, Takaya S, Fung JJ: Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis 1992; 12: 51-59.
18. Nikaein A, Backman L, Jennings L, Levy MF, Goldstein R, Gonwa T, Stone MJ, Klintmalm G: HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation 1994; 58: 786-792.
19. Charco R, Vargas V, Balsells J, Lazaro JL, Murio E, Jaurrieta E, Martorell J, Margarit C: Influence of anti-HLA antibodies and positive T-lymphocytotoxic crossmatch on survival and graft rejection in human liver transplantation. J Hepatol 1996; 24: 452-459.
20. Doran TJ, Geczy AF, Painter D, McCaughan G, Sheil AG, Susal C, Opelz G: A large, single center investigation of the immunogenetic factors affecting liver transplantation. Transplantation 2000; 69: 1491-1498.
21. Doyle HR, Marino IR, Morelli F, Doria C, Aldrighetti L, McMichael J, Martell J, Gayowski T, Starzl TE: Assessing risk in liver transplantation: special reference to the significance of a positive cytotoxic crossmatch. Ann Surg 1996; 224: 168-177.
22. Brown RS Jr, Russo MW, Lai M, Shiffman ML, Richardson MC, Everhart JE, Hoofnagle JH: A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003; 348: 818-825.
23. Suh KS, Kim SB, Chang SH, Kim SH, Minn KW, Park MH, Han KS, Lee KU: Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volume. Liver Transpl 2002; 8: 1109-1113.
24. Ashihara E, Tsuji H, Sakashita H, Haga H, Yurugi K, Kimura S, Egawa H, Manabe T, Uemoto S, Maekawa T: Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival. Transplantation 2007; 83: 506-509.
25. Takakura K, Kiuchi T, Kasahara M, Uryuhara K, Uemoto S, Inomata Y, Tanaka K: Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation. Clin Transplant 2001; 15: 309-316.
26. Kasahara M, Kiuchi T, Takakura K, Uryuhara K, Egawa H, Asonuma K, Uemoto S, Inomata Y, Ohwada S, Morishita Y, Tanaka K: Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection. Transplantation 1999; 67: 568-575.
27. Sugawara Y, Makuuchi M, Kaneko J, Kishi Y, Hata S, Kokudo N: Positive T lymphocytotoxic cross-match in living donor liver transplantation. Liver Transpl 2003; 9: 1062-1066. (Pubitemid 37304462)
28. Sugawara Y, Mizuta K, Kawarasaki H, Takayama T, Imamura H, Makuuchi M: Risk factors for acute rejection in pediatric living related liver transplantation: the impact of HLA matching. Liver Transpl 2001; 7: 769-773.
29. International Working Party: Terminology for hepatic allograft rejection. Hepatology 1995; 22: 648-654.
30. An International Panel: Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. Hepatology 2000; 31: 792-799.
31. Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, Everhart J, Detre KM: Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998; 28: 638-645.
32. Sugawara Y, Makuuchi M, Kaneko J, Saiura A, Imamura H, Kokudo N: Risk factors for acute rejection in living donor liver transplantation. Clin Transplant 2003; 17: 347-352. (Pubitemid 36958196)